1	National	_	NNP	_	_	3	NAME	_	_
2	Patent	_	NNP	_	_	3	NAME	_	_
3	Development	_	NNP	_	_	5	SBJ	_	_
4	Corp.	_	NNP	_	_	3	POSTHON	_	_
5	said	_	VBD	_	_	0	ROOT	_	_
6	it	_	PRP	_	_	7	SBJ	_	_
7	plans	_	VBZ	_	_	5	OBJ	_	_
8	to	_	TO	_	_	7	OPRD	_	_
9	purchase	_	VB	_	_	8	IM	_	_
10	as	_	RB	_	_	11	DEP	_	_
11	many	_	JJ	_	_	15	NMOD	_	_
12	as	_	IN	_	_	11	DEP	_	_
13	200,000	_	CD	_	_	11	DEP	_	_
14	common	_	JJ	_	_	15	NMOD	_	_
15	shares	_	NNS	_	_	9	OBJ	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	its	_	PRP$	_	_	22	NMOD	_	_
18	81%-controlled	_	JJ	_	_	22	NMOD	_	_
19	Interferon	_	NNP	_	_	22	NMOD	_	_
20	Sciences	_	NNP	_	_	22	NMOD	_	_
21	Inc.	_	NNP	_	_	22	NMOD	_	_
22	unit	_	NN	_	_	16	PMOD	_	_
23	in	_	IN	_	_	9	LOC	_	_
24	periodic	_	JJ	_	_	27	NMOD	_	_
25	,	_	,	_	_	27	P	_	_
26	open-market	_	JJ	_	_	27	NMOD	_	_
27	purchases	_	NNS	_	_	23	PMOD	_	_
28	.	_	.	_	_	5	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	200,000	_	CD	_	_	3	NMOD	_	_
3	shares	_	NNS	_	_	4	SBJ	_	_
4	are	_	VBP	_	_	0	ROOT	_	_
5	about	_	RB	_	_	7	NMOD	_	_
6	23	_	CD	_	_	5	DEP	_	_
7	%	_	NN	_	_	4	PRD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	Interferon	_	NNP	_	_	12	NMOD	_	_
10	's	_	POS	_	_	9	SUFFIX	_	_
11	common	_	JJ	_	_	12	NMOD	_	_
12	shares	_	NNS	_	_	8	PMOD	_	_
13	outstanding	_	JJ	_	_	12	APPO	_	_
14	,	_	,	_	_	4	P	_	_
15	excluding	_	VBG	_	_	4	ADV	_	_
16	National	_	NNP	_	_	17	NAME	_	_
17	Patent	_	NNP	_	_	19	NMOD	_	_
18	's	_	POS	_	_	17	SUFFIX	_	_
19	stake	_	NN	_	_	15	PMOD	_	_
20	.	_	.	_	_	4	P	_	_

1	Noting	_	VBG	_	_	18	ADV	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	recent	_	JJ	_	_	4	NMOD	_	_
4	Food	_	NNP	_	_	1	OBJ	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	Drug	_	NNP	_	_	8	NMOD	_	_
7	Administration	_	NNP	_	_	8	NMOD	_	_
8	approval	_	NN	_	_	5	CONJ	_	_
9	of	_	IN	_	_	4	NMOD	_	_
10	Interferon	_	NNP	_	_	14	NMOD	_	_
11	's	_	POS	_	_	10	SUFFIX	_	_
12	genital	_	JJ	_	_	14	NMOD	_	_
13	warts	_	NNS	_	_	14	NMOD	_	_
14	treatment	_	NN	_	_	9	PMOD	_	_
15	,	_	,	_	_	18	P	_	_
16	National	_	NNP	_	_	17	NAME	_	_
17	Patent	_	NNP	_	_	18	SBJ	_	_
18	said	_	VBD	_	_	0	ROOT	_	_
19	it	_	PRP	_	_	20	SBJ	_	_
20	believes	_	VBZ	_	_	18	OBJ	_	_
21	Interferon	_	NNP	_	_	23	NMOD	_	_
22	's	_	POS	_	_	21	SUFFIX	_	_
23	stock	_	NN	_	_	24	SBJ	_	_
24	is	_	VBZ	_	_	20	OBJ	_	_
25	undervalued	_	JJ	_	_	24	PRD	_	_
26	.	_	.	_	_	18	P	_	_

